← All algorithms
Perioperative Anaphylaxis
IgE-mediated (or pseudo-allergic) hemodynamic collapse from drug, latex, or transfusion exposure. Most common triggers in OR: NMBAs (rocuronium, succinylcholine), antibiotics, latex.
Recognition
- •Sudden hypotension + ↑HR after drug administration
- •Bronchospasm, ↑PIP, urticaria/flush, angioedema
- •Often within minutes of induction or antibiotic dose
Steps
- 1Stop the suspected trigger
- 2Call for help, 100% O₂, secure airway if not already
- 3Epinephrine titrated IV10–100 mcg IV bolus q1–2 min, escalating to 0.1–1 mg if cardiac arrest. IM 0.3–0.5 mg if no IV access.
- 4Rapid IV fluids1–2 L NS or LR; up to 35 mL/kg may be needed (massive third-spacing).
- 5Vasopressin 1–2 U bolus, then infusionEspecially if epi-refractory hypotension.
- 6Adjunct: H1 + H2 blockers + steroidAdjuncts only — they do not replace epi. Steroid for delayed/biphasic.
- 7Bronchodilators if wheezingAlbuterol nebulized + IV ketamine 0.5 mg/kg or epi nebulizer.
- 8Send tryptase 30 min, 2 h, and 24 h post-event
- 9Refer to allergist with drug + latex panel
Drugs + doses
| Drug | Dose | Note |
|---|---|---|
| Epinephrine | 10–100 mcg IV q1–2 min; 1 mg IV if arrest | |
| NS or LR | 20 mL/kg bolus, repeat | |
| Vasopressin | 1–2 U IV bolus, then 0.01–0.04 U/min | |
| Diphenhydramine (H1) | 25–50 mg IV | |
| Famotidine (H2) | 20 mg IV | |
| Hydrocortisone | 100–200 mg IV | |
| Glucagon | 1–5 mg IV (for β-blocker–refractory cases) |
Pitfalls
- !Diphenhydramine + steroid alone → patient deteriorates. Epi first, always.
- !Sugammadex can cause anaphylaxis itself (~1:2,500–20,000) — recognize.
- !Tryptase normal ≠ rule out anaphylaxis (especially non-IgE pseudoallergy).
Sources
- AAGBI 2024
- WAO Guidelines 2020
- ASA Practice Advisory
Anatomy reference
Sourced reference images. 4 matches for "immune system mast cell histamine".
Browse the full image library →Education only — not a substitute for facility protocols, MOC certification, or clinical judgment. Always follow your institutional crisis algorithm and confirm doses against current package inserts.



